Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.34T
Market cap1.34T
Price-Earnings ratio
47.05
Price-Earnings ratio47.05
Dividend yield
0.47%
Dividend yield0.47%
Average volume
3.77M
Average volume3.77M
High today
$1,427.75
High today$1,427.75
Low today
$1,412.00
Low today$1,412.00
Open price
$1,419.50
Open price$1,419.50
Volume
665.72K
Volume665.72K
52 Week high
$1,453.00
52 Week high$1,453.00
52 Week low
$850.51
52 Week low$850.51

Stock Snapshot

With a market cap of 1.34T, Eli Lilly(LLY) trades at $1,423.62. The stock has a price-to-earnings ratio of 47.05 and currently yields dividends of 0.47%.

During the trading session on 2026-11-11, Eli Lilly(LLY) shares reached a daily high of $1,427.75 and a low of $1,412.00. At a current price of $1,423.62, the stock is +0.8% higher than the low and still -0.3% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 665.72K, versus its average volume of 3.77M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,453.00 and a low of $850.51.

LLY News

Zacks 32m
ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win - Zacks Investment Research

...

ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win - Zacks Investment Research
Benzinga 2h
EXCLUSIVE: Lilly, Gilead Face Near-Term Drug Pricing Risks As Washington Turns Up Heat

The next wave of U.S. drug-price negotiations could put billions of dollars in pharmaceutical revenue under pressure, with Eli Lilly and Co (NYSE:LLY), Gilead S...

EXCLUSIVE: Lilly, Gilead Face Near-Term Drug Pricing Risks As Washington Turns Up Heat
Simply Wall St 17h
Eli Lilly Eyes First Oral OSA Approval After Phase 3 Foundayo Win

Eli Lilly (NYSE: LLY) reported that oral obesity drug Foundayo (orforglipron) produced significant benefits in a large Phase 3 OSA trial. The study showed mean...

Eli Lilly Eyes First Oral OSA Approval After Phase 3 Foundayo Win

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

24/7 Wall St. 22h
Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady
24/7 Wall St. 23h
Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week

ETF Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week By Ryne Mauck The ETF Examiner desk. Editor: Ryne Mauck. 𝕏 f ⧉ Quick R...

Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week
The Motley Fool 1d
Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?

Eli Lilly (LLY +0.54%) and Novo Nordisk (NVO -1.97%) are leading drugmakers in the highly lucrative GLP-1 market, where demand is through the roof for weight lo...

Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?
Zacks 1d
Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer

Chicago, IL – November 10, 2026 – Today, Zacks Equity Research discusses Eli Lilly (LLY Quick QuoteLLY - Free Report) , Novartis (NVS Quick QuoteNVS - Fr...

Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer
Seeking Alpha 2d
Eli Lilly, Novo weight-loss drugs to get rare vision loss warning

Eli Lilly, Novo weight-loss drugs to get rare vision loss warning Nov 09, 2026, 3:28 PM ET Eli Lilly and Company (LLY) Stock, NVO Stock NOVO:CA By : Jonathan Bl...

Eli Lilly, Novo weight-loss drugs to get rare vision loss warning
24/7 Wall St. 2d
Hims & Hers Crashes 10% Ahead of Q3 Earnings Despite Major Eli Lilly Deal

Continue Reading Live: Will Hims & Hers Rebound After Tonight’s Q2 Earnings? Hims and Hers Health heads into Q2 earnings carrying a brutal Q1 miss, margin comp...

Hims & Hers Crashes 10% Ahead of Q3 Earnings Despite Major Eli Lilly Deal
TipRanks 2d
Eli Lilly’s Obesity Pill Found to Help with Sleep Apnea

U.S. pharmaceutical giant Eli Lilly (LLY) has announced that its obesity pill Foundayo has been found to significantly reduce the severity of sleep apnea. A lat...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.